February 1, 2022
News Summary: Waters has acquired technology assets and intellectual property rights of Megadalton Solutions, an early-stage developer of charge detection mass spectrometry (CDMS). CDMS overcomes limitations of conventional mass spectrometry in characterizing complex large molecules in cell and gene therapies. CDMS technology will be further developed to extend capabilities of Waters’ mass spectrometry portfolio for [...]
February 1, 2022
CHELMSFORD, MASS. – AMETEK Spectro Scientific, one of the world’s largest suppliers of oil and fuel analysis instrumentation and software, announces the release of its online Fluid Management Academy (FMA). The FMA is an online learning platform, offering customers a range of courses about Spectro Scientific’s and Grabner Instruments’ fluid analysis products. Academy users access short [...]
KromaTiD Announces the Launch of Cell Culture Services
February 1, 2022
LONGMONT, Colo. -- Building on over ten years of experience in the cell culture and isolation of cell products, KromaTiD is excited to announce the launch of a comprehensive suite of Cell and Blood Culture growth, isolation, processing, and quality control services. Focused on the cell types most important for gene and cell therapy and oncology [...]
January 31, 2022
Tucson, AZ – Lightsense Technology, a pioneer of multi-spectroscopic solutions to address large problems in public health — from the opioid crisis to the pandemic, food safety and quality assurance in various supply chains — and Severn Safety Supply, a trusted supplier to Law Enforcement Organizations (LEOs) across the USA, today announced a strategic partnership to help [...]
January 31, 2022
SOUTH SAN FRANCISCO, Calif.--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today released its inaugural environmental social and governance (ESG) report highlighting Twist’s approach to sustainability, social responsibility and commitment to ethics. The full report is available to view at https://www.twistbioscience.com/company/esg. [...]
EXpressLO LLC Submits U.S. Patent Application for Cryo-EM Specimen Handling
January 31, 2022
LEHIGH ACRES, Fla. -- EXpressLO LLC is the most comprehensive provider of focused ion beam (FIB) ex situ lift out (EXLO) specimen preparation solutions for transmission electron microscopy (EM) and other analytical techniques. As of January 27, 2022, EXpressLO LLC submitted a patent application to the U.S. Patent and Trademark Office describing highly innovative methods and apparatus for [...]
DuPont Announces Price Increase for Ion Exchange Resins
January 31, 2022
Prices support supply reliability in face of rising production and shipping costs WILMINGTON, Del. -- DuPont (NYSE:DD) today announced an up to 15 percent price increase for products across its ion exchange resin portfolio, effective February 1, 2022 as local regulations and contracts allow. The new prices enable DuPont to provide customers with a reliable supply while [...]
January 31, 2022
VIENNA -- Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in its Series A funding round from a consortium of European and US investors led by Hadean Ventures and with participation from Lansdowne Partners, Helicase Venture as well as several undisclosed investors. Existing investors IST cube and tecnet equity [...]
Lightsense Technology and Carahsoft Join Together to Bring “DrugDetect” to Government Agencies
January 31, 2022
Enabling US Law Enforcement with New Illicit Drug Detection Technology & Devices TUSCON, Az. and RESTON, Va. — Lightsense Technology, a pioneer of developing multi-spectroscopic solutions to address large problems in public health — from the opioid crisis to the pandemic, food safety and quality assurance in various supply chains — and Carahsoft Technology Corp., [...]
January 31, 2022
Vancouver – British Columbia, January 31, 2022. Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (CNSX:LEXT.CN) (OTCQB:LEXTF) a biotechnology company focused on the development of analytical services and production of botanically derived psychedelics, is pleased to announce that, on January 17, 2022, its wholly-owned subsidiary, Egret Bioscience Ltd., was granted a two year long [...]
